期刊文献+

MID1在大肠癌组织中的表达及其对预后的意义 被引量:2

Prognostic significance of MID1 expression in colorectal carcinoma
下载PDF
导出
摘要 目的:探讨MID1在人大肠癌中表达的临床意义及其对术后生存时间的影响.方法:采用SP免疫组织化学法检测109例大肠癌手术切除组织标本中MID1的表达,分析MID1的表达与大肠癌的关系,用KaplanMeier和Cox回归分析法进行生存分析.结果:MID1的表达对大肠癌的术后的生存时间有显著影响(P<0.05);与大肠癌的淋巴结转移情况呈显著性负相关(r=-0.204,P=0.034<0.05);与大肠癌的浸润深度呈显著性负相关(r=-0.223,P=0.020<0.05);与大肠癌的分化程度呈显著性正相关(r=0.236,P=0.014<0.05);MID1的表达与大肠癌的年龄、性别及其病理类型没有关系.Kaplan-Meier生存曲线结果显示,随访期内MID1高中低各组7年累积生存率分别为69.2%、45.0%、30.0%;高中低各表达组患者术后平均生存时间分别为:91.101mo±6.127mo,69.389mo±7.512mo,50.358mo±8.091mo,Log-rank检验证明,整体水平及各组间水平均有统计学意义(P<0.05);经多因素Cox回归分析发现,MID1低表达、淋巴结的转移可显著增加患者的死亡风险(P<0.05).结论:MID1可以作为大肠癌分化、侵袭、淋巴结转移以及预后的一项指标. AIM:To detect the expression of midline 1 (MID1) in human colorectal carcinoma and to assess its prognostic significance.METHODS:Immunohistochemistry was used to detect the expression of MID1 protein in colorectal carcinoma specimens (n=109).The relationship between the survival of patients with colorectal cancer and the expression of MID1 was investigated.Survival analyses were performed using the Kaplan-Meier method and Cox regression model.RESULTS:MID1 expression significantly affected the survival of patients with colorectal carcinoma (P0.05).MID1 expression had a significantly negative correlation with lymph node metastasis (r=-0.204,P=0.034) and depth of invasion (r=-0.223,P=0.020),but was significantly positively correlated with differentiation de-gree (r=0.236,P=0.014).MID1 expression had no relationship with sex,age or tumor pathologic type.Kaplan-Meier analysis indicated that the 7-year cumulative survival rates for patients with high,medium and low MID1 expression were 69.2%,45.0% and 30.0%,respectively,and their mean survival time was 91.101 mo±6.127 mo,69.389 mo±7.512 mo,50.358 mo±8.091 mo.CONCLUSION:MID1 expression can be used as a parameter for the judgment of colorectal carcinoma differentiation,invasion and lymph node metastasis,and as a useful prognostic marker in patient with colorectal carcinoma.
出处 《世界华人消化杂志》 CAS 北大核心 2012年第2期113-118,共6页 World Chinese Journal of Digestology
关键词 MID1 免疫组织化学 大肠癌 预后 Midline 1 Immunohistochemistry Colorectal carcinoma Prognosis
  • 相关文献

参考文献31

  • 1Jemal A,Thomas A,Murray T,Thun M.Cancer statistics,2002.CA Cancer J Clin2002;52:23-47.
  • 2Zheng S,Cai SR.Colorectal Cancer Epidemiology and Prevention Study in China.Chin-Ger J Clin Oncol2003;2:72-75.
  • 3Sung JJ,Lau JY,Goh KL,Leung WK.Increasing incidence of colorectal cancer in Asia:implications for screening.Lancet Oncol2005;6:871-876.
  • 4Cainarca S,Messali S,Ballabio A,Meroni G.Functional characterization of the Opitz syndrome gene product(midin):evidence for homodimerization and association with microtubules throughout the cell cycle.Hum Mol Genet1999;8:1387-1396.
  • 5Tao H,Simmons BN,Singireddy S,Jakkidi M,Short KM,Cox TC,Massiah MA.Structure of the MID1tandem B-boxes reveals an interaction reminiscent of intermolecular ring heterodimers.Biochemistry2008;47:2450-2457.
  • 6Clifford DM,Wolfe BA,Roberts-Galbraith RH,McDonald WH,Yates JR,Gould KL.The Clp1/Cdc14phosphatase contributes to the robustness of cytokinesis by association with anillin-related Mid1.J Cell Biol2008;181:79-88.
  • 7So J,Suckow V,Kijas Z,Kalscheuer V,Moser B,Winter J,Baars M,Firth H,Lunt P,Hamel B,Meinecke P,Moraine C,Odent S,Schinzel A,van der Smagt JJ,Devriendt K,Albrecht B,GillessenKaesbach G,van der Burgt I,Petrij F,Faivre L,McGaughran J,McKenzie F,Opitz JM,Cox T,Schweiger S.Mild phenotypes in a series of patients with Opitz GBBB syndrome with MID1mutations.Am J Med Genet A2005;132A:1-7.
  • 8Schweiger S,Schneider R.The MID1/PP2A complex:a key to the pathogenesis of Opitz BBB/G syndrome.Bioessays2003;25:356-366.
  • 9Hao JM,Chen JZ,Sui HM,Si-Ma XQ,Li GQ,Liu C,Li JL,Ding YQ,Li JM.A five-gene signature as a potential predictor of metastasis and survival in colorectal cancer.J Pathol2010;220:475-489.
  • 10Okuda K,Sasaki H,Kawano O,Yukiue H,Yokoyama T,Yano M,Fujii Y.Epidermal growth factor receptor gene mutation,amplification and protein expression in malignant pleural mesothelioma.J Cancer Res Clin Oncol2008;134:1105-1111.

同被引文献20

  • 1李景南,李潇,钱家鸣,路新卿,杨红.K-ras基因突变通过调节E-cadherin/β-catenin/p120蛋白复合体形成和RhoA蛋白活性对结肠癌细胞株Caco-2转移的影响[J].中国医学科学院学报,2010,32(1):46-50. 被引量:10
  • 2吴健民.对肿瘤标志物的再认识[J].中华检验医学杂志,2005,28(1):11-13. 被引量:116
  • 3Ferlay J, Autier P, Boniol M, et al. Estimates of the cancer incidence and mortality in Europe in 2006[J]. Ann Oncol, 2007, 118(3) :581-592.
  • 4Cheng X, Chen VW, Steele B, et al. Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States, 1992-1997[J]. Cancer, 2001, 92(10) :2547-2554.
  • 5Konopke R, Distler M, Ludwig S, et al. Location of liver metastases reflects the site of the primary colorectal carcinoma [J]. Scand J Gastroenterol, 2007,43(2) : 192-195.
  • 6Patel K, Hoffman NE. The anatomical distribution of coloreetal polyps at colonoscopy [J]. J Clin Gastroenterol, 2001,33 (3): 222-225.
  • 7MeCashland TM, Brand R, Lyden E, et al. CORI Research Project. Gender differences in colorectal polyps and tumors [J]. Am J Gas troenterol, 2001, 96(3):882-886.
  • 8Ponz de Leon M, Sant M, Micheli A, et al. Clinical and pathologic prognostic indicators in colorectal cancer. A populationbased study[J]. Cancer, 1992, 69(3) :626-635.
  • 9Chiang JM, Chen MC, Changchien CR, et al. Favorable influ ence of age on tumor characteristics of sporadic colorectal adenocarcinoma: patients 30 years of age or younger may he a distinct patient group[J]. Dis Colon Rectum, 2003, 46(7):904 910.
  • 10Liang JT, Huang KC, Cheng AL, et al. Clinicopathological and molecular biological {eatures of colorectal cancer in patients less than 40 years ofage[J]. Br J Surg, 2003, 90(2) :205-214.

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部